By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Exosome Diagnostics 

1585 Broadway

New York  New York  10036  U.S.A.
Phone: n/a Fax: n/a



Company News
Exosome Diagnostics Release: Clinical Data For World's First Truly Non-Invasive Prostate Cancer Test Published In JAMA Oncology 4/12/2016 11:24:14 AM
Exosome Diagnostics ExoDx Prostate(IntelliScore): A More Precise, Genetically Informed Prostate Cancer Test From A Simple Urine Sample 1/26/2016 10:36:50 AM
Exosome Diagnostics Launches World’s First Exosomal RNA-Based Liquid Biopsy, ExoDx Lung(ALK) 1/21/2016 10:26:58 AM
Leading Liquid Biopsy Company, Exosome Diagnostics, Appoints Daniel Zabrowski As Board Member 1/13/2016 11:14:07 AM
Exosome Diagnostics Banks $60 Million Series B Financing 1/7/2016 5:56:57 AM
Exosome Diagnostics Appoints Raaj Venkatesan As Vice President Of Regulatory Affairs And Quality 12/22/2015 11:54:12 AM
Exosome Diagnostics Launches Clinical Commercialization Program For The Research Market 11/24/2015 12:13:50 PM
Exosome Diagnostics’ Exosomal RNA (exoRNA) Plus Cell-Free DNA (cfDNA) Liquid Biopsy Panel Demonstrates Superior Detection Of EGFR Activating And Resistance Mutations In NSCLC Versus cfDNA-Only Approach 11/9/2015 1:46:01 PM
Exosome Diagnostics’ Exosomal RNA Platform Demonstrates Enrichment Of Tumor-Specific Gene Changes In Response To Immunotherapy Treatment 11/9/2015 1:43:32 PM
Exosome Diagnostics To Present Data At The 26th AACR-National Cancer Institute-EORTC International Conference On Molecular Targets And Cancer Therapeutics 11/6/2015 11:42:41 AM